1Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hemotopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting -Airlie House, Virgina, November 1997. J Clin Oncol, 1999; 17: 3835-3849.
2Cairo MS, Raetz E, Lira MS, et al. Childhood and adolescent non-Hadgkin lymphoma: new insights in biology and critical challenges for the future. Pediatr Blood Cancer, 2005 ; 45 : 753-769.
3Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin' s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol, 1980;7:332-339.
4Unpttblished data. Annual workshop. Hong Kong Paediatric Haematology and Oncology Study Group.
5Cario MS, Bishop M. Tumor lysis syndrome: New therapeutic strategies and classification. Br J Haematol, 2004; 127:3-11.
6Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin ' s lymphoma. Am J Med, 1993; 94: 133-139.
7Alavi S, Arzanian MT, Abbasian MR, et al. Tumor lysis syndrome in children with non-Hodgkin lymphoma. Paediatr Hematol Oncol, 2006 ;23:65-70.
8Arseneau JC, Canellos GP, Banks PM, et al. American Burkitt's lymphoma: A clinicoopathologic study of 30 cases. Clinical factors relating to prolonged survival. Am J Med, 1975 ;58:314-321.
9Annemans L, Moeremans K, Lamotte M, et al. Incidence, medical resource utilisation and costs of hyeruricemia and tumor lysis syndrome in patients with acute leukemia and non-Hodgkin' s lymphoma in four European countries. Leuk Lymphoma, 2003 ;44: 77-83.
10Cohen LF, Balow JE, Magrath IT, et al. Acute tumor lysis syndrome: A review of 37 patients with Burkitt' s lymphoma. Am J Med, 1980;68:486-491.
